← Open Payments lookup

PEDRO MORANTE: Open Payments

NPI 1689038507 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,235 in 38 payments from 8 companies in 2025. Trend: 2023 $651 · 2024 $685 · 2025 $1,235

Food & beverage: $1,235
CompanyPaymentsAmount
Alkermes, Inc.15$373
Janssen Pharmaceuticals, Inc6$241
ABBVIE INC.11$202
Neurocrine BioSciences, Inc.2$149
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$122
Vanda Pharmaceuticals Inc.1$112
Lundbeck LLC1$19
Tris Pharma Inc1$17

Products named: ARISTADA, INVEGA SUSTENNA, VRAYLAR, INGREZZA, CAPLYTA, FANAPT, REXULTI, Dyanavel XR.

Industry payments across CA — which companies pay providers there.